KYOWA KIRIN, INC

Lobbying for KYOWA KIRIN, INC · Pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $150,000.00 expenses · posted Jul 17, 2026

Lobbying activity 2

Pharmacy

Trade/tariffs, pharmaceutical pricing/value and rare disease issues

Trade (domestic/foreign)

Tariffs & Trade policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.